Debnath Sourav, Singh Anurag Kumar, Rajotiya Sumit, Mishra Shivang, Pal Pusparghya, Raj Preeti, Bareth Hemant, Singh Mahaveer, Tripathi Pratik, Nathiya Deepak, Tomar Balvir Singh
Department of Pharmacy Practice, Nims University, Jaipur 303121, Rajasthan, India.
School of Health Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester M139PL, UK.
J Clin Med. 2025 Apr 17;14(8):2753. doi: 10.3390/jcm14082753.
: Frailty is a critical concern for chronic kidney disease (CKD) patients, contributing to increased vulnerability to adverse health outcomes and diminished quality of life. However, there is limited research on frailty's impact on health-related quality of life (HRQOL) among dialysis and pre-dialysis patients in the Indian context. : This study involved participants aged 18 and above with CKD stages 3-5. Frailty was assessed using the Morley FRAIL questionnaire, and HRQOL was measured using the RAND version of the KDQOL-36 Survey. Data were analyzed with SPSS version 29, focusing on the association between frailty and HRQOL domains. : Among the 147 CKD patients, 56.46% were frail, and 43.56% were non-frail. Significant differences were noted between frail and non-frail groups in age ( = 0.036), CKD stages ( < 0.001), nutritional status ( < 0.001), Charlson comorbidity index ( < 0.001), BMI ( < 0.001), GFR ( < 0.001), CRP ( = 0.006), and serum albumin ( = 0.002). Frailty is significantly associated with lower physical ( < 0.001) and mental ( < 0.001) quality of life. Negative associations between frailty and KDQOL-36 domains, especially symptom problems, PCS, and MCS, were established. : Our findings emphasize the importance of frailty screening in CKD patients. Early identification may help guide targeted strategies to support HRQOL. However, longitudinal studies are needed to assess frailty progression and the impact of potential interventions.
衰弱是慢性肾脏病(CKD)患者的一个关键问题,会导致他们更易出现不良健康结局,生活质量下降。然而,在印度背景下,关于衰弱对透析患者和透析前患者健康相关生活质量(HRQOL)影响的研究有限。
本研究纳入了年龄在18岁及以上的3 - 5期CKD患者。使用莫利衰弱问卷评估衰弱情况,使用KDQOL - 36调查的兰德版本测量HRQOL。数据采用SPSS 29版进行分析,重点关注衰弱与HRQOL各领域之间的关联。
在147例CKD患者中,56.46%为衰弱患者,43.56%为非衰弱患者。衰弱组和非衰弱组在年龄(P = 0.036)、CKD分期(P < 0.001)、营养状况(P <